These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20110666)

  • 1. Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.
    Hayden MR; Habibi J; Whaley-Connell A; Sowers D; Johnson M; Tilmon R; Jain D; Ferrario C; Sowers JR
    Am J Nephrol; 2010; 31(3):262-72. PubMed ID: 20110666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Johnson M; Tilmon R; Rehmer N; Rehmer J; Wiedmeyer C; Ferrario CM; Sowers JR
    Am J Nephrol; 2009; 30(4):354-60. PubMed ID: 19609077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.
    Habibi J; Hayden MR; Sowers JR; Pulakat L; Tilmon RD; Manrique C; Lastra G; Demarco VG; Whaley-Connell A
    Endocrinology; 2011 Feb; 152(2):659-68. PubMed ID: 21177830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.
    Manrique C; Lastra G; Habibi J; Pulakat L; Schneider R; Durante W; Tilmon R; Rehmer J; Hayden MR; Ferrario CM; Whaley-Connell A; Sowers JR
    Metabolism; 2011 Dec; 60(12):1757-66. PubMed ID: 21640361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
    Ma L; Gul R; Habibi J; Yang M; Pulakat L; Whaley-Connell A; Ferrario CM; Sowers JR
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2341-51. PubMed ID: 22447938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat.
    Hayden MR; Chowdhury NA; Cooper SA; Whaley-Connell A; Habibi J; Witte L; Wiedmeyer C; Manrique CM; Lastra G; Ferrario C; Stump C; Sowers JR
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F861-7. PubMed ID: 17032939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Nistala R; Hayden MR; Pulakat L; Sinak C; Locher B; Ferrario CM; Sowers JR
    Regul Pept; 2012 Jun; 176(1-3):36-44. PubMed ID: 22465166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.
    Whaley-Connell A; Habibi J; Panfili Z; Hayden MR; Bagree S; Nistala R; Hyder S; Krueger B; Demarco V; Pulakat L; Ferrario CM; Parrish A; Sowers JR
    Am J Nephrol; 2011; 34(2):115-25. PubMed ID: 21720156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.
    Zhou X; Ma L; Habibi J; Whaley-Connell A; Hayden MR; Tilmon RD; Brown AN; Kim JA; Demarco VG; Sowers JR
    Hypertension; 2010 Apr; 55(4):880-8. PubMed ID: 20176997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.
    Varagic J; Ahmad S; Brosnihan KB; Habibi J; Tilmon RD; Sowers JR; Ferrario CM
    Am J Nephrol; 2010; 32(6):557-66. PubMed ID: 21042014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats.
    Varagic J; Ahmad S; Voncannon JL; Moniwa N; Simington SW; Brosnihan BK; Gallagher PE; Habibi J; Sowers JR; Ferrario CM
    J Hypertens; 2012 Sep; 30(9):1766-74. PubMed ID: 22895019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.
    Pires MJ; Rodríguez-Peña AB; Arévalo M; Cenador B; Evangelista S; Esteller A; Sánchez-Rodríguez A; Colaço A; López-Novoa JM
    J Hypertens; 2007 Dec; 25(12):2486-96. PubMed ID: 17984671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.
    Sasser JM; Moningka NC; Tsarova T; Baylis C
    Life Sci; 2012 Jul; 91(1-2):54-63. PubMed ID: 22727796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats.
    Toblli JE; Cao G; Giani JF; Muñoz MC; Angerosa M; Dominici FP
    J Hypertens; 2011 Aug; 29(8):1613-23. PubMed ID: 21720265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats.
    Ye H; Ling S; Castillo AC; Thomas B; Long B; Qian J; Perez-Polo JR; Ye Y; Chen X; Birnbaum Y
    Hypertension; 2013 May; 61(5):1008-13. PubMed ID: 23460283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway.
    Whaley-Connell AT; Habibi J; Nistala R; DeMarco VG; Pulakat L; Hayden MR; Joginpally T; Ferrario CM; Parrish AR; Sowers JR
    Am J Nephrol; 2012; 35(1):90-100. PubMed ID: 22205374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
    Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.